Pulmonary emphysema in alpha-1 pi deficiency

Clinical trials for Pulmonary emphysema in alpha-1 pi deficiency explained in plain language.

Never miss a new study

Get alerted when new Pulmonary emphysema in alpha-1 pi deficiency trials appear

Sign up with your email to follow new studies for Pulmonary emphysema in alpha-1 pi deficiency, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for rare lung disease: protein infusions may slow emphysema

Disease control Ongoing

This study tests whether weekly infusions of Alpha-1 MP (a protein replacement) can slow lung damage in 345 people with emphysema caused by Alpha-1 antitrypsin deficiency. Participants receive one of two doses or a placebo for three years, with lung CT scans tracking changes. The…

Matched conditions: PULMONARY EMPHYSEMA IN ALPHA-1 PI DEFICIENCY

Phase 3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

Pulmonary emphysema in alpha-1 pi deficiency

Get alerted when new Pulmonary emphysema in alpha-1 pi deficiency trials appear

New hope for rare lung disease: protein infusions may slow emphysema